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Background: The definition of rapid eye movement (REM) sleep behavior disorder
(RBD) has varied over the years. Rapid eye movement sleep behavior disorder can
be considered isolated or idiopathic or can occur in the context of other disorders,
including trauma-associated sleep disorder (TSD) and overlap parasomnia. However,
whether trauma in RBD carries any prognostic specificity is currently unknown.
Study Objectives: To test the hypothesis that RBD secondary to trauma is less likely
to result in the development of neurodegeneration compared to idiopathic RBD (iRBD)
without trauma in the general population.
Methods: A retrospective cohort study of 122 consecutive RBD patients (103 males) at
two tertiary sleep clinics in Europe between 2005 and 2020 was studied. Patients were
diagnosed as having iRBD by video polysomnography (vPSG) and had a semi-structured
interview at presentation, including specifically eliciting any history of trauma. Patients
with secondary RBD to recognized causes were excluded from the study. Patients with
iRBD were categorized into three groups according to reported trauma history: (1) No
history of trauma, (2) traumatic experience at least 12 months prior to RBD symptom
onset, and (3) traumatic experience within 12 months of RBD symptom onset. Idiopathic
RBD duration was defined as the interval between estimated onset of RBD symptoms
and last hospital visit or death. Follow-up duration was defined as the interval between
iRBD diagnosis and last hospital visit or death.
Results: In a follow-up period of up to 18 years, no patient who experienced
trauma within 12 months preceding their iRBD diagnosis received a diagnosis of
a neurodegenerative disorder (n = 35), whereas 38% of patients without trauma
within the 12 months of symptom onset developed a neurodegenerative illness. These
patients were also significantly more likely to have a family history of α-synucleinopathy
or tauopathy.
Conclusions: The development of RBD within 12 months of experiencing a traumatic
life event, indistinguishable clinically from iRBD, did not lead to phenoconversion to a
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neurodegenerative disorder even after 18 years (mean follow up 6 years). We suggest
that a sub-type of RBD be established and classified as secondary RBD due to
trauma. Additionally, we advocate that a thorough psychological and trauma history be
undertaken in all patients presenting with dream enactment behaviors (DEB).
Keywords: RBD, trauma, REM-behavior disorder, dream enactment behaviors, DEB
DEFINITIONS
• RBD patients with no trauma history (Group 1)
• RBD patients with trauma that occurred >12 months before
RBD diagnosis (Group 2)
• RBD patients with trauma that occurred <12 months before
RBD diagnosis (Group 3).
INTRODUCTION
Rapid eye movement (REM) sleep behavior disorder (RBD)
is a REM parasomnia characterized by the loss of normal
muscle atonia during REM sleep, in association with complex
motor activity that usually represents dream enactment behaviors
(DEB) (1, 2). The prevalence of RBD has been estimated
to be between 0.5 and 2% in the general population (3,
4), with a higher incidence in men after the age of 50
years (5). Rapid eye movement sleep behavior disorder is
categorized as either idiopathic/isolated, occurring in the absence
of other diseases, or secondary. In secondary RBD, there
are other underlying causes present, such as brain lesions,
neurological diseases, or provoking antidepressant medications
(2). Idiopathic, or isolated, RBD (iRBD) is increasingly but not
uniformly considered an α-synucleinopathy (6, 7). However,
not all iRBD patients develop a neurodegenerative disorder (7).
Whether this is due to insufficient time for the full clinical
characteristics of neurodegenerative disease to develop or a lack
of α-synuclein/tau pathology in the brain of these patients or an
undisclosed history of trauma is unknown at present.
By way of comparison, a recently described parasomnia,
trauma-associated sleep disorder (TSD), has substantial
symptomatic and clinical overlap with RBD (8, 9) and is
thought to be induced by severe psychological trauma. Only
a small number of TSD laboratory cases have been reported
in the literature (10). As a result, and due to overlap with
RBD, identifying TSD as a distinct parasomnia has remained
controversial. Additionally, all TSD cases reported in the
Abbreviations:AD, Alzheimer’s disease; AHI, apnoea hypopnea index; BMI, body
mass index; DLB, dementia with Lewy bodies; EMG, electromyography; iRBD,
idiopathic RBD; LPT, lateral pontine tegmentum; LDTN, laterodorsal tegmental
nucleus; LC, locus coeruleus; MCRF, medullary magnocellular reticular formation;
MSA, multiple systems atrophy; PD, Parkinson’s disease; PPT; pedunculopontine;
PPT, peduncupontine; PSG, polysomnography; PC, precoeruleus; PTSD, post-
traumatic stress disorder; RBD, rapid eye movement sleep behavior disorder;
RSWA, REM sleep without atonia; RN, red nucleus; SCN, spinal cord neuron; SC,
subcoeruleus; SN, substantia nigra; TSD, trauma-associated sleep disorder; vlPAG;
ventrolateral periaqueductal gray; vPSG, video polysomnography; WASO, wake
time after sleep onset.
literature have been active or ex-military personnel, whereas
cases from the general population remain to be described (10).
This study aimed to test the hypothesis that nocturnal dream
enactment accompanied by REM sleep without atonia (RSWA)
has different prognostic implications in iRBD in the context of
trauma, in patients recruited from the general population. Given
the overlap between RBD diagnostic criteria and reported TSD
symptoms, as well as the association between RBD symptom
onset in the context of a traumatic experience in a previously
reported small number of iRBD patients (11), we hypothesized
that patients from the general population with a history of trauma
would be phenotypically dissimilar to patients with iRBD and
no recent (<1 year) history of trauma. Twelve months from
trauma to DEB was chosen as this was the longest time between
trauma exposure and symptom onset reported in the case studies
of TSD by Mysliwiec et al. (10). An additional control group of
iRBD patients that reported traumatic event exposure prior to 12
months of RBD symptom onset was also included, to ascertain
whether timing of trauma was relevant.
METHODS
This was a retrospective, cohort study of consecutive RBD
patients referred to tertiary sleep referral centers in the
United Kingdom and the Czech Republic between May 2005
and February 2020. Formal ethical approval was not deemed
necessary by the local research committee since we utilized
only anonymised, secondary data derived as part of standard
clinical practice. All research was carried out in accordance
with Helsinki criteria (World Medical Association, 2001) (12).
In our practice, in Edinburgh, it is standard to take a mental
health history and to ask about trauma and adverse adult
and childhood experiences as part of the patient interview
in any patient presenting with a parasomnia. Furthermore,
this work was considered to be a service evaluation whereby
the information was taken from routine practice and no new
questionnaires/interview questions were introduced to gather
this information. The dataset derived in the present manuscript
was de-identified prior to it being captured and analyzed and all
data are presented in aggregated form. This is standard procedure
as laid out in the Caldicott principles.
Patient data were obtained using NHS electronic patient notes
accessed through TrakCare (www.intersystems.com/TrakCare),
a system used to record clinical data in secondary care (hospital)
environments. All data were extracted between January 2019
and March 2020. The patient data obtained were collected
between May 2005 and February 2020 by medical health
care professionals.
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At patient presentation, a semi-structured interview was
conducted, documenting clinical characteristics, sleep habits,
dream content of any reported dreams and history of trauma.
Patients were excluded from this study if neurodegenerative
syndromes manifested prior to RBD symptom development or
if patients were on antidepressant therapy, or had a diagnosis of
narcolepsy, as these patients were considered to have secondary
RBD according to the ICSD-3 Diagnostic Criteria defined as
follows: repeated episodes of sleep related vocalizations or complex
motor behaviors, documented by polysomnography to occur during
REM sleep, with REM sleep demonstrating RSWA, and is not better
explained by another sleep disorder, mental disorder, medication,
or substance use (2). Patients were also excluded if they had a
diagnosis of overlap parasomnia.
Trauma was defined using the ICD-10 trauma definition: . . .a
“delayed or protracted response to a stressful event or situation
(of either brief or long duration) of an exceptionally threatening
or catastrophic nature, which is likely to cause pervasive distress
in almost anyone” (13). For comparative purposes, the DSM-
5 criteria (“actual or threatened death, serious injury, or
sexual violence”) were also used (14). Trauma assessment was
undertaken by a single medical professional in a blinded manner.
Patients were categorized into three groups: (1) No history of
trauma, (2) traumatic experience <12 months prior to RBD
symptom onset, (3) traumatic experience >12 months prior
to RBD symptom onset. No patient in the iRBD group had
been diagnosed with post-traumatic stress disorder previously or
on presentation. A family history of an alpha-synucleinopathy,
dementia/tauopathy, or other neurodegenerative condition was
also noted.
Rapid eye movement sleep behavior disorder duration was
defined as the interval between self-reported/estimated onset
of RBD symptoms and last follow-up visit or death. Follow-
up duration was defined as the interval between RBD diagnosis
and last follow-up visit or death. All RBD patients met full
International Classification for Sleep Disorders-3 criteria (2).
Patients with RSWA considered secondary to other etiologies,
e.g., medication, were not included in this study.
Patients underwent overnight video polysomnography
(vPSG) within 1–6 months of presentation. Video-PSGs
were scored by registered sleep physiologists using AASM
guidelines (15).
Patients were included in the study if any of the following
instances of REM without atonia were present:
A) Excessive sustained Chin EMG activity of 2x Stage R atonia
was observed for at least 50% of an epoch of REM.
B) 50% of 3-s mini epochs contained bursts of transient Chin
or Leg EMG activity (0.1–5 s) at least four times greater than
Stage R atonia.
The RSWA index (percentage of Stage R with atonia) was not
calculated, as this optional reporting statistic was added into
AASM Scoring Manual at version 2.6 (2020), after data collection
for this study had taken place. The AASM Scoring Manual
Version 2.6 has an extra rule regarding EMG tone in REM—Any
Chin EMG >2 times Stage R atonia was observed (between 5
and 15 s), and uses 2x not 4x for transient muscle activity. The
TABLE 1 | Type of traumatic event and time at which it was experienced in
relation to iRBD onset.
Trauma type
(ICD-10 criteria)
Trauma greater than 12
months prior to
symptom onset (n = 14)
Trauma within 12
months of RBD
symptom onset (n = 37)
Physical or sexual
abuse
21% (n = 3) 16% (n = 6)
Witness of the
death of a loved
one*
14% (n = 2) 16% (n = 6)
Operation* 7% (n = 1) 11% (n = 4)
War related 7% (n = 1) 3% (n = 1)
Road traffic
accident
0% (n = 0) 3% (n = 1)
Near drowning 29% (n = 4) 0% (n = 0)





14% (n = 2) 26% (n = 9)
Not disclosed 7% (n = 1) 26% (n = 9)
Traumatic event types experienced by patients.
*Events not classified in DSM V as trauma.
methods used in this study reflect the fact that version 2.4 was
used for analysis of data.
Statistical analysis was undertaken using IBM SPSS Statistics
for Windows (Version 24.0. Armonk, NY: IBM Corp.). The
Kolmogorov-Smirnov test was used to assess for normality. For
discrete variables, the Chi-square test was used. For continuous
variables, one-way ANOVA and the Kruskal-Wallis tests were
used. Results are reported as number and percentage or mean
± standard deviation (sd). Kaplan-Meier analysis was used to
assess risk of developing α-synucleinopathies, and the Mantel
Cox test was used to compare the survival curves between
groups. All tests were two-tailed where appropriate for subgroup
comparisons, and significance was set at p ≤ 0.05. As this
was a finite population and as there are no previous studies
differentiating these populations, power calculations were not
considered necessary.
RESULTS
The RBD cohort overall comprised 103 men (84.4%) and 19
women (15.6%), with a mean age of estimated RBD onset of
53.7 ± 13.9 years (range: 19–76 years). The mean age at RBD
diagnosis was 59.1 ± 12.1 years (range: 25–89 years) and the
mean duration of RBD prior to presentation was 5.7 ± 4.4 years
(range: 0.5–13 years). Thirty-seven patients (30.3%) reported
trauma <12 months preceding RBD symptom onset, 14 patients
(11.5%) reported trauma >12 months preceding RBD symptom
onset, with all meeting the ICD-10 classification of trauma and
53% meeting the stricter standard DSM-V criteria for trauma
(Table 1). The remaining 71 patients (58.2%) did not report any
traumatic life events. Clinical characteristics across the groups
are shown in Table 2. All four patients who had a medical
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TABLE 2 | Differences in clinical characteristics across groups diagnosed with iRBD.
Clinical characteristics No trauma
(n = 71)
Trauma greater than 12
months prior to RBD
symptom onset (n = 14)
Trauma within 12 months of




62:9 11:3 30:7 0.57
Estimated age at RBD onset
(years)
(n = 56)
56.21 ± 10.85 49.87 ± 7.18 54.61 ± 14.19 0.42
Age at RBD diagnosis (years)
(n = 114)
60.92 ± 10.44 54.50 ± 9.36 57.53 ± 15.28 0.13
Duration of RBD (years)
(n = 115)
5.62 ± 4.81 7.43 ± 4.16 5.09 ± 3.68 0.34
AHI (<5 normal, <15 Mild OSA),
<30 Moderate OSA, ≥30 Severe
OSA
(n = 103)
20.99 ± 18.15 28.35 ± 37.21 12.42 ± 10.64 0.08
BMI
(n = 106)
29.54 ± 5.51 31.17 ± 8.59 28.49 ± 5.71 0.40
Smoker
(n = 67)
14:25 (56%) 3:6 (50%) 5:14 (36%) 0.77
Alcohol use disorder (DSM V)
(n = 116)
4 (6%) 0 (0%) 1 (3%) 0.58
Constipation
(n = 84)
5 (14%) 1 (7%) 1 (3%) 0.47
Self-report of anosmia or changes
in sense of smell (n = 84)
6 (14%) 3 (21%) 4 (15%) 0.87
Family history of
alpha-synucleinopathies (n = 109)
8 (14%) 3 (27%) 0 (0%) 0.05
Subsequent diagnosis of
neurodegenerative disorder
26 (37%) 6 (43%) 0 (0%) 0.01
Differences in clinical characteristics between groups (Group 1, n= 71; Group 2, n= 14; Group 3, n= 37). Results are reported as mean± standard deviation or number and percentage.
history of sleepwalking had onset in childhood and their NREM
parasomnia did not recur in adulthood.
Incidents of violent nocturnal behaviors (e.g., kicking,
punching, biting, and scratching) or occasions during which
the bed partner was hurt did not differ significantly across
the three groups (see Figure 1A). Likewise, there was no
significant differences across groups in terms of dream themes
(see Figure 1B; p > 0.05, data not shown). Both trauma groups
reported dreams related to past experiences.
There were no significant differences in REM sleep latency
or any additional PSG variables across trauma groups (Table 3).
Measurement parameters of autonomic activity (time point and
length of measurement) have not been specified by Mysliwiec
et al. (8) and so could not be replicated in our study.
Self-report of anosmia or recent reduction in sense of smell
was 15% across all groups at presentation, with no statistically
significant difference across groups (Table 2).
In our cohort, 32 patients (26.2%) received a diagnosis, in each
case verified by a specialist neurologist, of a neurodegenerative
disease after a mean follow-up duration of 870 ± 1,109 days
(range: 0.5–18 years) from symptom onset. Disorders that
manifested during follow-up (which were not present at RBD
diagnosis) were: Parkinson’s disease (n = 20), Lewy Body
dementia (n = 7), Progressive supranuclear palsy (n = 1),
Alzheimer’s disease (n = 2), and Motor neurone disease with
frontotemporal dementia (n = 2). Of these patients, 26 (81.3%)
had no trauma history (PD n= 15, DLB n= 5, PSP n= 1, AD n=
2,MND n= 2), and the remaining 6 (18.7%) patients experienced
trauma longer than 12 months prior to RBD symptom onset (PD
n = 6). No patients in Group 3 received a neurodegenerative
disease diagnosis during follow-up (see Figure 2), whereas 36.6%
of patients in Group 1 and 42.9% of patients in Group 2 went on
to develop a neurodegenerative disorder. A significant difference
was found in neurodegenerative disease development across
groups (p= 0.01).
No patients in Group 3 had a family history of
neurodegenerative disorders, whereas eight patients (14%)
in Group 1 and three patients (27%) in Group 2 had a family
history of α-synucleinopathies (p= 0.05); see Table 2.
DISCUSSION
This is the first study to our knowledge to report in detail on
trauma associated with “iRBD” onset. Because all patients were
phenotypically indistinguishable at presentation and fulfilled
criteria for iRBD clinically, we argue that a history of trauma
when clearly established as occurring within 12months of dream-
enactment behavior, mandates that it be classified as secondary
RBD. Our results demonstrate a significant difference in the
disease-free survival rate of patients who had experienced trauma
Frontiers in Neurology | www.frontiersin.org 4 November 2021 | Volume 12 | Article 710584
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FIGURE 1 | RBD characteristics (A) and dream themes (B) across groups. (A) RBD characteristics for RBD patients with no trauma history (Group 1); trauma which
occurred within 12 months of RBD diagnosis (Group 3); trauma which occurred >12 months before RBD diagnosis (Group 2). Percentage of patients is relative to
trauma group for (A,B). No significant difference between groups was found in the reported dream recall, incidence of violent nocturnal behavior or incidence in
(Continued)
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FIGURE 1 | which a bed partner was hurt (p > 0.05, data not shown). (B) Differences in self-reported dream themes for RBD patients between groups (no trauma
history; trauma which occurred prior to RBD diagnosis.). No significant difference was found in the percentage of dream themes between groups (p > 0.05, data not
shown). Error bars are excluded as bars represent strict counts.
TABLE 3 | Differences in PSG variables across iRBD groups.
PSG variables No trauma
(n = 71)
Trauma greater than 12 months prior
to RBD symptom onset (n = 14)
Trauma within 12 months of
RBD symptom onset (n = 37)
P-value
REM sleep latency (min) 137 ± 78.72 117 ± 65.92 106 ± 68.92 0.45
Sleep latency (min) 45 ± 35.60 41 ± 32.29 44 ± 74.03 0.16
WASO (min) 120 ± 54.15 105 ± 42.27 102 ± 55.36 0.28
REM sleep (%) 15 ± 7.49 18 ± 9.50 19 ± 9.20 0.10
Stage N1 (%) 7 ± 10.29 5 ± 7.39 6 ± 8.28 0.67
Stage N2 (%) 60 ± 17.38 66 ± 16.33 56 ± 16.79 0.19
Stage N3 (%) 10 ± 11.76 5 ± 5.56 13 ± 12.20 0.05
Sleep efficiency (%) 64 ± 14.58 66 ± 16.43 68 ± 18.34 0.26
Differences in PSG variables across groups (no trauma history, n = 53; trauma which occurred >12 months prior to RBD diagnosis, n = 13; trauma which occurred within 12 months
prior to RBD diagnosis, n = 30). Results are reported as mean ± standard deviation or number. PSG variables did not differ significantly across groups (p > 0.05).
FIGURE 2 | Kaplan-Meier plot of neurodegenerative disease-free survival in Group 1 (blue line), Group 2 (yellow line), and Group 3 (green line). Disease-free survival in
RBD patients differed significantly across groups (p = 0.01).
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within 12 months of RBD onset as compared to those who had
never experienced trauma, or who had experienced historical
trauma, prior to RBD onset. At present, it is debatable whether
the cohort presented in this study represents “non-military” TSD,
as none had a formal diagnosis of PTSD despite reporting often
very severe and impactful experiences.
Longitudinal studies have consistently demonstrated that
many RBD patients go on to develop an α-synucleinopathy
or (less commonly) tauopathy (16). Postuma et al. reported a
conversion rate to a neurodegenerative syndrome of 6.3% per
year after diagnosis (17) and found 73.5% patients converted
after 12-year follow-up. Similar results were found in several
other longitudinal studies of RBD cohorts summarized in a
recent systematic review and meta-analysis (18). Currently,
no reports of phenoconversion to neurodegenerative disease
in TSD patients exist. In our cohort, no patients in Group
3 and 38% of patients in Groups 1 and 2 were diagnosed
with a neurodegenerative disorder. As the follow-up period
for most patients in our cohort was under 10 years, this
result may be inconclusive; it is possible that more patients
may go on to develop a neurodegenerative disease, if the
estimates are correct (17, 19). Nevertheless, our observation has
important implications for the understanding of the pathological
mechanisms of RSWA and iRBD in the context of trauma
and for phenotyping patients appropriately in clinic as well as
discussing prognosis.
Our iRBD patient cohort was comprised predominantly of
men, consistent with previous findings (17, 18). The reason
for this sex difference is unclear. A plausible explanation may
be referral bias, as clinical expression of RBD in males has
been reported to be more violent and vigorous than in females
(11), making males more prone to seek medical attention. Until
this study, no female patients had been reported with trauma
associated RBD (10).
Rapid eye movement sleep behavior disorder patients younger
than 40 years often have secondary forms of RBD (1, 2). Trauma-
associated sleep disorder patients reported in the literature are
also considerably younger (8), which may be attributable to the
demographics of the military. Thirteen percent of patients with
recent trauma in our cohort were under 40 years of age, as
compared to 3% with historical or no trauma.
In this study, no differences in sleep latency, sleep efficiency,
or sleep architecture across groups were found, although both
the recent trauma group and historical trauma group had
decreased REM latency compared to the group without trauma.
These findings, particularly in relation to REM, are interesting
considering increased REM sleep latency has been found in
fear conditioned rats and mice (20). Fear conditioned mice
also have decreased REM epochs (21) and REM length (22).
Alternatively, in the absence of aversive stimuli, animals display
increased percentages of REM sleep, and duration during the
sleep period (21). Fear conditioned animals have been proposed
as models for trauma (20), suggesting that trauma affects REM
sleep architecture, which may explain the decreased REM latency
reported in TSD and the two groups with trauma in our study (8).
Unfortunately, human studies are less conclusive: although REM
latency may be affected by trauma, in our study, REM latency was
decreased. While some PSG studies of traumatized individuals
with and without PTSD report REM sleep abnormalities (23),
others do not (24).
Invoking the studies on TSD when considering trauma,
symptoms of autonomic hyperarousal are included them as part
of the diagnostic criteria for TSD (10). Yet only one incident of
hyperarousal is documented in TSD patients in the literature and
measurement parameters are not specified (8). For this reason,
autonomic activity measurements could not be determined in
our study using any valid/validated criteria, and our patients
should therefore be considered as having RBD secondary to
trauma. During normal REM sleep, there is marked suppression
of sympathetic activity (25) and in previous reports, RBD patients
have been shown to lack autonomic reactivity such as tachypnea
and tachycardia despite vigorous limb movements (1).
Our data concurs with findings from previous RBD studies
in that dream content mainly involves defense against people
or animals and escape from life-threatening situations (11, 26).
We found no significant differences in dream themes across
groups. Interestingly, patients with and without a trauma history
reported dreams that replayed prior life experiences. This has
not been reported previously for RBD patients (6, 11), however
is consistent with reports in TSD (10). Although in both cases
dreams are unpleasant, RBD dreams tend to have similar themes
unrelated to past experiences, whereas TSD dreams involved
accounts of previous, personal events (10). This type of personal
trauma-associated nightmare has been extensively reported in
patients with post-traumatic stress disorder (27), indicating that
these nightmares are possibly a consequence of trauma.
Reports also suggest that TSD involves more extensive and
vigorous movements than RBD (10). We found no differences
in violent nocturnal behaviors or incidents in which bed partners
were hurt between iRBD patients that experienced trauma and
patients with no trauma history. Furthermore, none of the
patients displayed disruptive nocturnal behavior during non-
REM sleep. One potential explanation may be because patients
with concomitant disorders of arousal are likely to attract a
diagnosis of overlap disorder and were not included in the
cohort analyzed.
We found lower percentages of anosmia or a reduction in
sense of smell at diagnosis, and of constipation than reported by
Postuma et al. (17), which may be related to our reliance on self-
report without objective assessment. Constipation prevalence
was 8% across groups, also significantly lower than in the 2019
multicenter study (17).
Functional neuroimaging in humans has found changes in
volumetric and cerebral blood flow patterns in wakefulness
and sleep, following traumatic event exposure (28). Structures
affected include several brainstem nuclei implicated in REM
sleep generation and the amygdala (28) which is critical for the
processing of fear consolidation, emotional distress, and fear
extinction, and is hyperactive in humans following a traumatic
experience (29). Liu et al. found that fear conditioning in mice
resulted in increased activity in the raphe nucleus and locus
coeruleus via the amygdala, with increased twitching during REM
sleep (30). This disruption of REM sleep is thought to occur
via maintained inhibition of cholinergic activity (21). Animal
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studies have also shown that projections from the amygdala may
generate vocalizations via activation of the central gray matter
(31). Thus, the possibility that the amygdala may contribute to
RSWA may be a direction for future research. However, only
a small number of laboratory studies on the effects of trauma
on sleep disturbances exist, and current animal models do not
effectively mirror human symptoms (21).
Some limitations of this study must be noted. Healthy
controls with and without trauma are necessary to ensure
there is no independent association between trauma and
neurodegeneration. To the best of our knowledge, no studies have
previously tested such a link. Secondly, a major limitation was
that trauma was used as a biomarker. A temporal correlation
between traumatic experience and RBD symptom onset does not
indicate causation in all cases i.e., in some patients, RBD onset
may have occurred regardless of traumatic experience. Thus,
using an alternative measure, such as autonomic hyperarousal
which occurs exclusively in TSD and not RBD would have
been beneficial. This was not possible for this study as set
thresholds for autonomic hyperarousal measures do not appear
to exist. Thirdly, trauma reports relied on patient self-report
and individuals may feel reluctant to recount their traumatic
event due to resistance to re-experiencing emotion associated
with the event (32). Therefore, the actual number of traumatized
RBD patients may be higher than self-reported in this study.
Not all participants were formally assessed by a psychiatrist as
part of standard clinical care but all participants at our clinics
are made aware that psychological, mood, and traumatic life
experiences may have a bearing on their sleep and sleep quality so
are more likely to disclose important information in this regard.
Lastly, it is important to note that psychological trauma is very
common in the community. In Scotland alone, a population-wide
survey published in 2019 showed that 15% of people had suffered
significant adverse childhood experiences, with 7% reporting
sexual abuse in childhood (33).
In our cohort, 32 patients (26%) developed a
neurodegenerative disorder during the follow-up period (range:
0.5–18 years from diagnosis), with a mean RBD duration of 5.7
± 4.46 years. However, RBD can precede neurodegeneration
by more than 20 years, and phenoconversion has been reported
to be as high as 80% (19). More patients may be expected to
phenoconvert to a neurodegenerative disorder in the future,
and longitudinal follow-up of the patients is ongoing. Finally,
this was a retrospective cohort study with some data subject
to individual recall bias, although bed partners assisted in
completing the sleep history wherever possible. Currently, we
are prospectively documenting phenoconversion in our growing
cohort of patients. Additionally, the validation of sensitive and
specific biomarkers will allow us to ascertain better our clinical
observations in the very near future (34).
Finally, scoring criteria that are forever being revised present
another limitation to studies in this area, making comparisons
to older studies more difficult. It is important to point out that
the AASMManual for Scoring Sleep for Associated Events added
two new rules regarding RSWA in the latest version (version
2.6), after data collection and sleep scoring of this cohort was
completed. The new additions change both the amplitude of
EMG required to score phasic events, and importantly insert an
optional reporting measure of RSWA %, which is a potential
biomarker in predicting neurodegeneration.
In conclusion, we found that the development of RBD
clinically with RSWA on polysomnography within 12
months of experiencing a traumatic life event has not led
to phenoconversion to a neurodegenerative disorder to date.
Patients presenting with the emergence of DEB in the context
of recent trauma were also unlikely to have a family history
of α-synucleinopathies or tauopathies. We suggest that a sub-
type of RBD classified as secondary RBD due to trauma be
established. Lastly, this study also highlights the importance of a
family history of neurodegeneration as a prognostic marker of
earlier decline in iRBD, as has been previously noted (35, 36).
Long-term follow-up of the cohort continues.
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